CEO for Danish Neutraceutical start-up
Gi Group Holding
Dato: for 1 dag siden
Kontrakttype: Fuld tid
Fjernarbejde
If You Want To Be The Front Figure Of a Start-up With a Groundbreaking Product Portfolio And – If We May Say So Ourselves – a Huge Potential To Influence The Next Generation Of Neutraceuticals, Then Here Is a Unique Opportunity, You Cannot Miss
At Mmimetika we’re developing a unique nutraceutical that mimics the body’s metabolic response to hard exercise and fasting. A growing body of independent scientific evidence is documenting the potential of our solutions on an array of bodily functions via better metabolic control and in support of longevity.
We are a startup founded in 2022. We are now focusing on finalizing Novel Foods and GRAS approvals in key markets, preparing volume production ramp-up, and paving our way into the global B2B marketplace.
We are looking to raise a series A financing in 2026. This funding round will enable us to take our first products to market in late 2026 or early 2027 and to then grow the company.
We are looking for an entrepreneurial CEO with relevant food ingredient or similar industry expertise who can lead our commercialization efforts and help raise our series A financing.
The expected starting date for our new CEO is the beginning of 2026 or earlier.
You will thrive in this role, if the following points resonate with you:
Requirements
To succeed in the position, we expect you to:
Having been through a similar journey before will be a very large plus!
Work-hours & Compensation
We are looking for full-time employment – a person who wants to be the face of Mmimetika and commit to this journey with us as we grow. Since we are at the pre-commercial stage, you should expect a realistic base salary + an attractive warrant package as initial compensation. Upon reaching key milestones such as securing commercial agreements with ingredients companies/B2B partners, as well as series A funding and revenue generation, your base salary will increase markedly as the business matures.
What should motivate you, is our unique mimetic solutions and the chance to be a key part of a successful scale-up within next-generation neutraceuticals!
Work Place
Optimally, you should be located in or able to relocate to Denmark.
Most of the team currently reside near Aarhus University campus, but the right candidate might work from anywhere within the country or even abroad, as long as you are able to travel and be present as needed.
Start Date
We are looking for our new CEO to start no later than the beginning of 2026.
Application Process
To simplify the application process, a cover letter is not required. We aim to maintain a fair and unbiased recruitment process and request that you refrain from including a photo in your CV.
Please submit your CV as soon as possible, using the application form.
Applications will be reviewed on a rolling basis.
Expect that the initial meetings will be handled by our executive search partners from Gi Life Sciences – see contact details below.
In Case You Are Curious To Learn More About Us:
Read more about our roadmap here: https://mmimetika.com/roadmap/
Read more about the team here: https://mmimetika.com/organization/
Read more about our technological foundation here: https://mmimetika.com/foundation/
You are also welcome to follow us on LinkedIn: https://www.linkedin.com/company/mmimetika-biosciences-aps/
Contact
Gi Life Sciences is supporting us in this Executive Search, and we would encourage you to reach out to Søren Spanner Bach (+45 28 43 13 02 or [email protected]) or Anna Rasmussen (+45 29 61 00 81 or [email protected]) in case you have questions.
At Mmimetika we’re developing a unique nutraceutical that mimics the body’s metabolic response to hard exercise and fasting. A growing body of independent scientific evidence is documenting the potential of our solutions on an array of bodily functions via better metabolic control and in support of longevity.
We are a startup founded in 2022. We are now focusing on finalizing Novel Foods and GRAS approvals in key markets, preparing volume production ramp-up, and paving our way into the global B2B marketplace.
We are looking to raise a series A financing in 2026. This funding round will enable us to take our first products to market in late 2026 or early 2027 and to then grow the company.
We are looking for an entrepreneurial CEO with relevant food ingredient or similar industry expertise who can lead our commercialization efforts and help raise our series A financing.
The expected starting date for our new CEO is the beginning of 2026 or earlier.
You will thrive in this role, if the following points resonate with you:
- You get caught by being part of a company and team bringing unique products to the market for the benefit of an aging population.
- You thrive in a fast-paced, entrepreneurial setting that emphasizes quick decision-making within a flat, agile, and bureaucracy-free organization.
- You’re excited to join a start-up transitioning to scale-up, where “wearing multiple hats” and adaptability are key to success.
- You cope well with uncertainty and can see yourself embark on the demanding process of series A fundraising.
- Help raise our series A fundraising round.
- Lead the development of our global B2B go-to-market strategy.
- Execute said go-to-market strategy.
- Build and scale the organization as the business matures.
Requirements
To succeed in the position, we expect you to:
- Have a good understanding of the tightly regulated nutraceuticals market. Ideally, you have worked with commercializing neutraceuticals, novel ingredients, food supplements, vitamins, or similar.
- Have a detailed understanding of raising a series A financing round. Ideally, you have raised Venture Capital before.
- Have experience building a commercial organization from scratch.
Having been through a similar journey before will be a very large plus!
Work-hours & Compensation
We are looking for full-time employment – a person who wants to be the face of Mmimetika and commit to this journey with us as we grow. Since we are at the pre-commercial stage, you should expect a realistic base salary + an attractive warrant package as initial compensation. Upon reaching key milestones such as securing commercial agreements with ingredients companies/B2B partners, as well as series A funding and revenue generation, your base salary will increase markedly as the business matures.
What should motivate you, is our unique mimetic solutions and the chance to be a key part of a successful scale-up within next-generation neutraceuticals!
Work Place
Optimally, you should be located in or able to relocate to Denmark.
Most of the team currently reside near Aarhus University campus, but the right candidate might work from anywhere within the country or even abroad, as long as you are able to travel and be present as needed.
Start Date
We are looking for our new CEO to start no later than the beginning of 2026.
Application Process
To simplify the application process, a cover letter is not required. We aim to maintain a fair and unbiased recruitment process and request that you refrain from including a photo in your CV.
Please submit your CV as soon as possible, using the application form.
Applications will be reviewed on a rolling basis.
Expect that the initial meetings will be handled by our executive search partners from Gi Life Sciences – see contact details below.
In Case You Are Curious To Learn More About Us:
Read more about our roadmap here: https://mmimetika.com/roadmap/
Read more about the team here: https://mmimetika.com/organization/
Read more about our technological foundation here: https://mmimetika.com/foundation/
You are also welcome to follow us on LinkedIn: https://www.linkedin.com/company/mmimetika-biosciences-aps/
Contact
Gi Life Sciences is supporting us in this Executive Search, and we would encourage you to reach out to Søren Spanner Bach (+45 28 43 13 02 or [email protected]) or Anna Rasmussen (+45 29 61 00 81 or [email protected]) in case you have questions.
Se flere Fjernjob